sp will bottom up soon

microtrader,

Revenue will build up step by step, KSX focused on the milestone achieved in last 10 month, which has resulted in some major approval and contract for its product.

"The company is now focussing its efforts on early commercialization of its products particularly in the AsiaPac, European and North American markets."

yes we are still at early commercialization stage, If you look at the Cochlear, Resmed, they all take time to expand revenue from less than $1 million to billions, after they got major approvals.

The next milestone KSX needs to achieve is listing on NSDAQ, this will further open the USA market, this is also the reason KSX appointed Mr. Michael Thomas as new CEO.

Listing on NASDAQ also has great chance for SP tripled in short term, this is my experience.

Although SP is still at record low, I like KSX's current expanding strategy:

1) signed a deal with Omron Healthcare ??one of the
world's leading manufacturers and distributors of health care products.

2) major ongoing strategic focus for us in the Asia Pacific region.

3) appointed Mr. Michael Thomas as new CEO to expanding sales into the US 15 billion market.

4) Listing on NASDAQ, attract investors around the world, not only in Australia. The move is also to enable the investment in and the trade of KSX stock by various investment in the US that are currently unable to participate in an exchange outside of the US.

5)the Company is pleased with its ongoing discussions with leading medical device companies in relation to broader strategic relationships and alliances. (media mentioned Philip.)


I reckon there will be plenty of announcements flow into the the market within next 2 month, at SP 1--1.3c it's no points to sell shares at this obvious bottom price. better to hold and patiently wait for these announcements.

I am 100% sure that the NASDAQ news alone, will let us see SP double overnight.

1) As for KSX's products, I also have strong confidence:

The WHolter??is the world?s first approved device to record and quantify the presence of nocturnal wheeze and cough in patients at home.

"world?s first approved device "


this means KSX's WHolter??Service is the new standard: just like people check blood pressure using blood pressure units,Personal WheezoMeters would be New Paradigm in Asthma Management.

Simply, just because it's "world?s first approved device "

2) Insurer support:

"In some markets, we are getting up to 40% reimbursement rate from private insurers, considered to be significantly more effective than most other new devices in the market place."

"In the US, the Company has received CPT III codes for some of its key products" once the patients know they can claim money back form the insurers, the revenue of WHolter??will soar like a rocket!